Workflow
Veeva Data Cloud
icon
Search documents
Bristol Myers Squibb Adopts Veeva Systems Inc. (VEEV)’s Veeva Vault CRM, Boosting Market Confidence
Yahoo Finance· 2025-10-01 17:55
Core Insights - Veeva Systems Inc. is recognized as one of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years, highlighting its strong market position and growth potential [1] - The company is expanding its influence in the life sciences industry through its cloud-based platforms, serving over 1,500 global customers [1] - Veeva Systems operates as a Public Benefit Corporation, indicating a commitment to balancing stakeholder interests [1] Financial Performance - Veeva Systems reported a revenue increase of 16.7% year-over-year, with a free cash flow of approximately $1.18 billion as of August 22 [3] - The company reinvests its free cash flow into growth initiatives rather than distributing dividends [3] - Analysts project an average price target suggesting nearly 14% upside, with a forward P/E ratio indicating confidence in continued double-digit revenue growth [3] Strategic Developments - Bristol Myers Squibb's adoption of Veeva Vault CRM strengthens Veeva's market position and reflects growing confidence in its offerings [2][4] - The company is focusing on the increasing demand for digital transformation in healthcare, integrating AI capabilities into its platforms [4] - Veeva Systems is positioning itself as a leader in cloud-based, generative AI-enabled solutions for pharmaceutical and biotechnology clients [4] Future Outlook - Veeva Systems will host a Virtual Investor Day on October 16, 2025, to outline future strategies and product innovations [2]
Veeva Announces Fiscal 2026 First Quarter Results
Prnewswire· 2025-05-28 20:05
Core Insights - Veeva Systems Inc. reported total revenues of $759.0 million for the first quarter of fiscal 2026, representing a 17% increase year over year [1][6] - Subscription services revenues reached $634.8 million, up 19% from the previous year [1][6] - The company achieved a revenue run rate goal of $3 billion for 2025, indicating strong growth and innovation [6] Financial Performance - Operating income for the first quarter was $233.7 million, a 51% increase from $155.2 million a year ago [6] - Non-GAAP operating income was $349.9 million, up 34% from $260.9 million year over year [6] - Net income for the quarter was $228.2 million, a 41% increase compared to $161.7 million in the same period last year [6] - Non-GAAP net income was $327.8 million, reflecting a 33% increase from $247.0 million year over year [6] - Fully diluted net income per share was $1.37, compared to $0.98 a year ago, while non-GAAP fully diluted net income per share was $1.97, up from $1.50 [6] Strategic Initiatives - Veeva AI is set to enhance productivity and automation in the life sciences sector, with its first release planned for December 2025 [6] - The company showcased innovations at the Commercial Summit, including AI Agents aimed at improving operational efficiency [6] - Veeva expanded its commercial data offerings with the launch of Veeva CRM Pulse, enhancing its data cloud capabilities [6] Guidance and Outlook - For the fiscal second quarter ending July 31, 2025, Veeva expects total revenues between $766 million and $769 million [6] - The company anticipates non-GAAP operating income between $335 million and $337 million for the same period [6] - For the fiscal year ending January 31, 2026, Veeva projects total revenues between $3,090 million and $3,100 million [6]
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
Prnewswire· 2025-05-06 11:03
Group 1: Event Overview - Veeva Systems announced the 2025 Veeva Commercial Summit scheduled for May 13-14 in Boston, featuring keynote speakers from leading biopharma companies [1][2] - The summit will focus on innovations and strategies for coordinated customer engagement through AI and data alignment [1][3] Group 2: Keynote Highlights - Veeva CEO Peter Gassner will present on the integration of AI into the Vault Platform and Veeva applications, highlighting ongoing innovations in Veeva Commercial Cloud and Veeva Data Cloud [2] - Other presenters include representatives from ANI Pharmaceuticals, Gamida Cell, NewAmsterdam Pharma, Orchard Therapeutics, and Sobi, sharing best practices for emerging biotechs [2] Group 3: Industry Impact - The summit aims to enhance collaboration among sales, marketing, and medical teams to create more effective customer-centric experiences [3] - Veeva Commercial Summit is recognized as one of the largest industry events in North America for commercial and medical affairs leaders [3] Group 4: Company Background - Veeva Systems is a global leader in cloud software for the life sciences industry, serving over 1,000 customers, including major biopharmaceutical companies and emerging biotechs [4] - The company is committed to balancing the interests of all stakeholders, including customers, employees, and shareholders [4] Group 5: Company Strategies - AstraZeneca is standardizing analytics across its brands to enhance marketing reach and performance [6] - Bayer is focusing on customer-centric engagement through Vault CRM [6] - Boehringer Ingelheim is connecting scientific insights to drive personalized conversations with key opinion leaders [6] - Eli Lilly is streamlining workflows and aligning global teams to deliver impactful experiences at scale [6] - Johnson & Johnson and Madrigal are building modern data foundations for greater efficiency and field impact [6]